Evotec SE EVO
NASDAQ EVO
$1.67 +0.05 (+3.09%)
At close: Sep 17, 2026 · 4:00 PM EDT

Evotec SE (EVO) Liabilities and Shareholders Equity (2009 - 2026)

Evotec SE's (EVO) quarterly Liabilities and Shareholders Equity came in at $1.8 billion in Q2 2026, down 10.62% year-over-year from $2.0 billion in Q2 2025, and down 4.7% quarter-over-quarter from $1.9 billion in Q1 2026.

Analysis

Evotec SE (EVO) Liabilities and Shareholders Equity (2009 - 2026) Analysis & Trends

Evotec SE has disclosed Liabilities and Shareholders Equity across 10 years of filings, most recently posting $1.8 billion for Q2 2026.

  • In Q2 2026, Liabilities and Shareholders Equity fell 10.62% year-over-year to $1.8 billion; the TTM figure through Jun 2026 stood at $7.8 billion (down 6.08% YoY), while the FY2025 annual figure was $1.9 billion, down 6.45% from the prior year.
  • Liabilities and Shareholders Equity came in at $1.8 billion for Q2 2026 at Evotec SE, down from $1.9 billion in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $2.5 billion in Q2 2023 to a low of $1.8 billion in Q2 2026.
  • Average Liabilities and Shareholders Equity over 5 years is $2.2 billion, with a median of $2.1 billion recorded in 2025.
  • Year-over-year, Liabilities and Shareholders Equity gained 9.43% in 2022 and slipped 15.67% in 2024.
  • Over 5 years, Liabilities and Shareholders Equity stood at $2.3 billion in 2022, then increased by 5.24% to $2.4 billion in 2023, then fell by 15.67% to $2.0 billion in 2024, then slipped by 2.38% to $2.0 billion in 2025, then slipped by 8.3% to $1.8 billion in 2026.
  • Per Business Quant data, the three most recent Liabilities and Shareholders Equity figures were $1.8 billion in Q2 2026, $1.9 billion in Q1 2026, and $2.0 billion in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Iqvia Holdings 44.72 Bn 42.64 Bn 1.44 Bn 29.88 Bn
2 Medpace Holdings 17.37 Bn 16.87 Bn 201.64 Mn 2.06 Bn
3 Icon 13.65 Bn 12.72 Bn 479.29 Mn 16.40 Bn
4 Charles River Laboratories International 13.13 Bn 12.94 Bn 452.07 Mn 7.53 Bn
5 Fortrea Holdings 1.89 Bn 1.72 Bn 139.20 Mn 2.71 Bn
6 Evotec SE 574.75 Mn 148.87 Mn - 1.83 Bn
7 Ginkgo Bioworks Holdings 439.63 Mn 355.09 Mn 18.44 Mn 990.05 Mn
8 Champions Oncology 69.43 Mn 65.03 Mn 7.70 Mn 33.29 Mn
9 MindWalk Holdings 51.76 Mn 46.29 Mn 1.61 Mn 12.42 Mn
10 VivoSim Labs 1.37 Mn 1.37 Mn - 3.85 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.83 Bn
Mar 31, 2026 1.92 Bn
Dec 31, 2025 2.00 Bn
Sep 30, 2025 2.07 Bn
Jun 30, 2025 2.05 Bn
Mar 31, 2025 2.05 Bn
Dec 31, 2024 2.04 Bn
Sep 30, 2024 2.19 Bn
Mar 31, 2024 2.40 Bn
Dec 31, 2023 2.42 Bn
Jun 30, 2023 2.51 Bn
Dec 31, 2022 2.30 Bn
Sep 30, 2022 2.28 Bn
Mar 31, 2022 2.45 Bn
Dec 31, 2021 2.56 Bn
Sep 30, 2021 2.08 Bn
Dec 31, 2020 1.74 Bn
Dec 31, 2019 12.69 Mn
Sep 30, 2010 230.11 Mn
Jun 30, 2010 192.99 Mn